60 DEGREES PHARMACEUTICALS, INC.

SXTP ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Balance Sheet
Annual Quarterly

Balance Sheet

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Assets
Cash & Equivalents $1.0M $3.3M $1.5M $4.1M $2.0M $3.5M $1.7M $3.3M
Accounts Receivable $567.0K $335.8K $509.6K $674.0K $295.0K $488.2K $486.7K $323.8K
Inventory $877.9K $910.6K $656.9K $527.0K $799.4K $773.2K $442.8K $452.0K
Total Current Assets $3.7M $6.3M $4.9M $6.3M $3.8M $5.7M $5.4M $6.9M
Property, Plant & Equipment $242.7K $259.7K $246.4K $227.8K $193.9K $155.8K $149.8K $155.3K
Goodwill
Intangible Assets (Excl. Goodwill) $308.7K $243.2K $224.4K $152.4K $143.7K $149.8K $157.1K $264.4K
Total Assets $4.3M $6.8M $5.4M $6.7M $4.2M $6.0M $5.8M $7.4M
Liabilities
Accounts Payable
Total Current Liabilities $1.6M $1.9M $1.8M $2.2M $1.7M $1.8M $1.7M $1.3M
Long-Term Debt $150.0K $150.0K $144.0K $150.0K $150.0K $150.0K $147.1K $150.0K
Total Liabilities $1.8M $2.0M $2.0M $2.3M $1.8M $1.9M $1.8M $1.5M
Stockholders' Equity
Retained Earnings $-52.2M $-50.0M $-47.9M $-46.5M $-44.1M $-42.4M $-40.5M $-38.5M
Total Stockholders' Equity $2.6M $4.8M $3.5M $4.4M $2.4M $4.1M $4.0M $6.0M
← Newer Page 1 of 2 Older →